20
siRNA-Encapsulated Nanoparticles for Targeting Dorsal
Root Ganglion (DRG) in Diabetic Neuropathic Pain . . . . . . . . . . . .
369
Ranjana Bhandari, Priya Badyal, Garima Khanna, and Anurag Kuhad
21
EGFR-Targeted Quinazoline Clubbed Heterocycles as
Anticancer Agents . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
387
Vivek Panwar, Kritika Mukherji, Manjunath Ghate, Deepak K. Jindal,
and Deepak Kumar
22
Therapeutic Human Monoclonal Antibodies . . . . . . . . . . . . . . . . . .
401
Satish Kumar Gupta and Piyush Chaudhary
23
Unleashing Potential of Bone Mimicking Nanodimensional
Hydroxyapatites and Their Biomedical Applications . . . . . . . . . . . .
419
Seema Kapoor, Uma Batra, and Suchita Kohli
24
Recent Progress in Applications of Magnetic Nanoparticles
in Medicine: A Review . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
455
Renu, Jaspreet Kaur, Sonal Singhal, and Anupama Kaushik
25
Chimeric Antigen Receptor T Cell Therapy: A Cutting-Edge
Therapy for Multiple Myeloma . . . . . . . . . . . . . . . . . . . . . . . . . . . .
475
Eshu Singhal Sinha
26
Nanoparticle-Associated Lipopeptides: A New Class of
Antimicrobials . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
483
Vivek Chauhan, Priya Gautam, and S. S. Kanwar
27
Antimicrobial Applications of Engineered Metal-Based
Nanomaterials . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
495
Moondeep Chauhan, Gurpreet Kaur, Bunty Sharma,
and Ganga Ram Chaudhary
Part III
Traditional Drugs
28
Strengthening Immunity: Ayurveda and Medicinal Plants . . . . . . .
525
D. R. Nag and Akshay Nag
29
The Pathophysiology of Liver Disorders and Pharmacotherapy
Options with Special Reference to Traditional Herbal Medicines:
A Comprehensive Review . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
549
Hasandeep Singh, Tanveer Singh, Harpal Singh Buttar, Sarabjit Kaur,
Saroj Arora, Istvan G. Télessy, and Balbir Singh
30
Polymeric Vehicles for Controlled Delivery of Ayurvedic
Drugs for Wound Management . . . . . . . . . . . . . . . . . . . . . . . . . . . .
585
Arpan Biswas, Pralay Maiti, and Manoranjan Sahu
Contents
ix